AstraZeneca CEO says new global trial on COVID-19 vaccine likely
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine candidate, the company's CEO tells Bloomberg.
National drug shortage triggers some heart testing delays in Alberta doctors say
A countrywide shortage of drug used for heart imaging is sparking testing delays for some Alberta cardiology patients.
Comments
Post a Comment